Compare DraftKings Inc (DKNG) vs Heron Therapeutics Inc (HRTX) Price & Performance

DraftKings IncTrade

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs Heron Therapeutics Inc — how do they compare? DraftKings Inc trades at $25.21 (market cap $12.05B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: DraftKings Inc is far larger — about 190× Heron Therapeutics Inc's market cap, and DraftKings Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

	DKNG	HRTX
Market Cap	$12.05B	$63.41M
Sector	Consumer Cyclical	Health
52-Week High	$48.23	$1.49
52-Week Low	$20.72	$0.32
Enterprise Value	$12.98B	$161.31M

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DraftKings Inc

No Aura AI signal available yet.

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings faces decline as prediction markets outpace traditional sportsbooks, shares down 30% YTD.Seeking Alpha · 1 day agoBearish DraftKings Q2 misses earnings but shows strong growth in Predictions platform, stock remains a hold ahead of NFL season.24/7 Wall Street · 1 day agoNeutral DraftKings' prediction markets drive rapid growth, reshaping its national sports betting strategy.PYMNTS · 4 days agoBullish View details →

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.